Introduction
============

Repairing bone defects remains a major clinical problem in the fields of periodontology and oral implantology.[@b1-ijn-14-2683],[@b2-ijn-14-2683] Guided bone regeneration (GBR) is a widely applied, effective approach to treat alveolar bone defects around dental implants.[@b3-ijn-14-2683] Harnessing the endogenous regeneration potential of bone, the membrane used for GBR prevents the ingrowth of the epithelium or fibroblasts into the bone defect site[@b4-ijn-14-2683]--[@b6-ijn-14-2683] and acts as a space holder for delayed osteogenesis.[@b7-ijn-14-2683] The components of GBR membranes should meet specific prerequisites in addition to biocompatibility, non-immunogenicity, and nontoxicity, such as cell occlusivity, tissue integration, space-maintaining ability, nutrient transfer, and ease of use in clinical settings.

Currently, two types of membranes are used in clinical applications: non-resorbable and resorbable membranes. Non-resorbable membranes, such as expanded polytet-rafluoroethylene (e-PTFE), have proven to be very effective in preventing soft tissue invasion[@b8-ijn-14-2683],[@b9-ijn-14-2683] but need to be removed in a second-stage operation. Resorbable membranes, such as collagen membranes, do not need to be removed and have a GBR effect.[@b10-ijn-14-2683] In theory, the degradation time of resorbable membranes should be long enough to achieve bone regeneration before membrane disintegration. However, degradation rates are rapid and unpredictable, despite the use of various cross-linking techniques, and this impairs barrier function during the 4--6-month period required for complete healing and regeneration.[@b11-ijn-14-2683] An important issue with collagen membranes and e-PTFE membranes is their weak mechanical properties; they frequently require reinforcement with titanium mesh or filling with less degradable hydroxyapatite in the targeted repair region. However, these materials require a second surgery for removal, and exposure/infection rates are as high as 20%--44%.[@b12-ijn-14-2683],[@b13-ijn-14-2683] These limitations of current therapies have stimulated the development of new membrane materials. Synthetic membranes prepared using various materials, such as polyglycolides, polylactides, and copolymers, are sufficiently biocompatible and biodegradable for use as barrier membranes.[@b14-ijn-14-2683]--[@b18-ijn-14-2683] However, conventional fabrication techniques utilize toxic solvents that adversely affect cells and tissues if they are not completely removed. Furthermore, it is difficult to adjust the thickness, pore size, or external shape of fabricated scaffolds and to maintain architectural consistency.[@b19-ijn-14-2683]--[@b21-ijn-14-2683]

As a kind of heat-resistant cross-linking polyester, polyglycerol sebacate (PGS) is characterized by biocompatibility, elasticity to resist tissue compression, and flexible fabrication styles, including salt leaching and electrospinning. We therefore proposed that PGS could be an ideal biomaterial for GBR applications. We fabricated GBR membranes using PGS and investigated the impact of scaffold pore size on osteogenesis. PGS microporous membranes with various pore sizes were fabricated using the salt-leaching technique. Some related experiments in vivo have shown that microporous membranes with a pore size of 25--32 µm can not only promote osteogenesis but also increase volume, height, and compression modulus of bone.[@b21-ijn-14-2683]

Materials and methods
=====================

Fabrication of PGS biological membranes with different pore sizes
-----------------------------------------------------------------

PGS was dissolved in tetrahydrofuran (20%), and salt fusion and particulate leaching methods were used to fabricate porous scaffolds (thickness=1.0 mm, pore size=25, or 53 µm, porosity=90%), as described previously; the compressive modulus of the scaffolds was 4.05--1.30 kPa, as previously reported.[@b22-ijn-14-2683] Scaffolds were cut into 2.25 cm^2^ sheets (square) and autoclaved. Scaffolds were purified by serially soaking in 75%, 50%, and 30% ethanol, followed by soaking in PBS. A PGS biological membrane mold and holder were made using a standard microscope slide (1 mm thickness) by splicing and bonding. The holder was used when the PGS material was added dropwise. The hollow part of the mold was a square area of 15×15 mm.

Characterization of the PGS biological membranes by scanning electron microscopy (SEM) and tensile tests
--------------------------------------------------------------------------------------------------------

The cross-section and longitudinal section of the PGS biological membrane were glued to an aluminum base with carbon fiber tape. After metal spraying, SEM was used for observations and imaging, and the pores of the PGS biological membranes were measured (n=5).

For the tensile test, the dehydrated PGS biological membrane was cut into a square block of 10×15 mm and fixed to the mechanical sensor on the frame of a small tensile tester using a self-regulating measurement clip. The free ends of the upper and lower clips were parallel. After the instrument was started, the speed of adjustment was 2 mm/min and the maximum tension was 10 N. The instrument continued to apply a tensile force of 2 mm/min until the biological membrane was broken. During the pull process, the instrument recorded the instantaneous pull and pull length values 250 times/second. The corresponding stress--strain curves were obtained by calculating the stress--strain values, and the elastic modulus of each biological membrane was calculated.

Animal groups and surgery
-------------------------

In this study, all animal experiments followed the strict procedures approved by the Institutional Animal Care and Use Committee of Fourth Military Medical University. The experimental procedure was approved by the ethics committee of the Fourth Military Medical University and was performed in accordance with the Code of Ethics (Ethical Accreditation No 2015 kq-022). All of the surgical operations were performed under systemic and local anesthesia, and all efforts were made to minimize suffering. Feeding and housing conditions were in accordance with standard animal care procedures. A total of 28 male New Zealand rabbits weighing 1,500--1,800 g were randomly divided into four groups: 25 µm PGS membrane (n=8), 53 µm PGS membrane (n=8), collagen (Bio-Gide, Geistlich, Switzerland) membrane (n=8), and a blank control group (n=4). Each rabbit underwent an operation on the left and right tibiae of the lower limb. Fourteen animals were sacrificed at each time point (4 and 12 weeks) for further analysis.

Based on the preoperative weight, 0.2--0.3 mL of sierra oxazine hydrochloride was injected into the local muscle. After the anesthesia took effect, 1.5--2 mL of preoperatively prepared 3% pentobarbital sodium was injected into the local muscle again. The rabbit was then completely anesthetized, and the skin at the proximal end of the tibia near the knee joint was prepared. The operative region was disinfected with 75% anhydrous ethanol. Securing the limbs, an incision was made on the sagittal plane of the proximal end of the tibia, followed by muscular dissection and complete exposure of the bone surface.

A bone defect with a diameter of 8 mm was created on the upper end of the tibia using a trephine bar (Microtech Inc., Tokyo, Japan) and covered with the prepared square membrane (12 mm in side length, n=4). The 25 µm PGS biological membrane, 53 µm PGS biological membrane, or collagen (Bio-Gide) membrane were placed on the surface of the surgical bone defect ([Figure 1H](#f1-ijn-14-2683){ref-type="fig"}). All biological membranes were cut in advance to obtain 12×12 mm blocks. In the blank control group, no material was used to cover the surgical bone defect. The periosteum and the muscle as well as the skin were sutured. During the operation, the operative area was washed and cooled continuously with 0.9% normal saline. Subsequently, the rabbit periosteum and epidermis were sutured with 6--0 and 4--0 silks, respectively. Thereafter, the rabbits were given free access to water and food under standard living conditions.

Micro-computed tomography (CT) scanning
---------------------------------------

After 4 and 12 weeks of in vivo incubation, four animals in each membrane group and two animals in the blank control group were sacrificed. Bone samples were harvested from the tibia using saws. Micro-CT scanning was performed to evaluate all bone samples. A three-dimensional visible representation of the constructs and animals was obtained and used for further analysis after reconstructing the imaging data using NRecon software (Version 1.5.1.4, Skyscan, Bruker Corporation, Karlsruhe, Germany). The ratio of the ossification volume to total construct volume (bone volume to tissue volume \[BV/TV\]) for each sample in different groups was compared using micro-CT software (Inveon Research Workplace, Siemens, Germany).

Histological observation
------------------------

Bone samples were fixed with 4% paraformaldehyde for 24 hours. Fixed samples were decalcified in 10% EDTA for 15 days and dehydrated. After they were embedded in paraffin, the samples were cross-sectioned (6 µm thickness). Sections were dewaxed, hydrated in xylene and a series of alcohols, and stained with H&E and Masson's trichrome for general histology and bone evaluation. The stained sections were observed using a charge-coupled device (CCD) camera (DS-Fi2) equipped with an optical microscope (ECLIPSECI-L; Nikon Corporation, Tokyo, Japan). The image analysis system (Image-Pro Plus 6.0; Media Cybernetics Corporation, Maryland, USA) was used to quantitatively evaluate and analyze newly formed bone in bone defects. The percentage of new bone area was calculated by determining the new bone area as a proportion of the defect area.

Data analyses
-------------

All quantitative results are expressed as mean ± SD. Statistical analysis was performed using SPSS 17.0 (SPSS Inc., Chicago, IL, USA). Kruskal--Wallis ANOVA was used for comparisons among multiple groups, followed by Dunn--Bonferroni tests. The Mann--Whitney *U* test was used for two-group comparisons. Two-tailed *p*-values of \<0.05 were considered statistically significant.

Results
=======

Characteristics of the PGS porous membrane
------------------------------------------

The microarchitectures of the fabricated PGS membranes were evaluated by SEM ([Figure 1A](#f1-ijn-14-2683){ref-type="fig"}).

Highly porous structures could be observed on both sides and inner parts, and these pores were interconnected. Owing to the difference in pore size, the bulk densities of the 25 µm and 53 µm PGS membranes were 0.256±0.003 and 0.164±0.004 g/mm^3^, respectively. The density of the commercial collagen membrane (Bio-Gide), used as a control, was 0.107±0.002 g/mm^3^ ([Figure 1E](#f1-ijn-14-2683){ref-type="fig"}). Due to the elastomeric nature of heat-crosslinked PGS materials, an enhanced material density will inevitably increase resilience. The 25 µm pore size microstructure of the PGS membranes exhibited a much denser structure ([Figure 1A](#f1-ijn-14-2683){ref-type="fig"}) and thus a stronger ability to resist tissue compression. The conventional tensile test showed that the 25 µm PGS membrane and 53 µm PGS membrane had lower mechanical strength and breaking strain than the collagen membranes ([Figure 1B and C](#f1-ijn-14-2683){ref-type="fig"}), whereas no significant differences were observed between the 25 µm PGS membrane and 53 µm PGS membrane in this test. The elastic modulus of the 25 µm PGS membrane was 31.33±2.42 kPa and that of the 53 µm PGS membrane was 21.48±2.03 kPa, and these values differed significantly (n=5, *p*\<0.05; [Figure 1D](#f1-ijn-14-2683){ref-type="fig"}).

An advantage of the porous structure is the adequate pathways for the passage of liquids and small molecules, which is favorable for tissue growth beneath the GBR membrane.[@b23-ijn-14-2683]--[@b25-ijn-14-2683] We thus compared the permeability of the membranes using an in vitro model ([Figure 1F](#f1-ijn-14-2683){ref-type="fig"}). As shown in [Figure 1F](#f1-ijn-14-2683){ref-type="fig"}, owing to the dense double-layer structure, Bio-Gide membranes showed a good blocking effect against macromolecules (the glucose molecules were approximately 0.7 nm). The PGS membrane with a 25 µm pore size exhibited better permeability than that of the Bio-Gide membrane; although glucose osmosis was not significantly different from that of the Bio-Gide membrane in the first 15 min, osmosis was significantly higher in the later stage. Owing to its loose and porous structure, the permeability of the 53 µm PGS membrane was the highest among the groups. These results confirmed that the porous PGS membrane is superior to the collagen membrane with respect to the rapid diffusion of glucose and other nutrients ([Figure 1G](#f1-ijn-14-2683){ref-type="fig"}).

Microporous PGS improved osteogenesis
-------------------------------------

To quantitatively evaluate the regenerated bone, micro-CT scanning images and analysis results at the end of 4 and 12 weeks after implantation are shown in [Figures 2](#f2-ijn-14-2683){ref-type="fig"} and [3](#f3-ijn-14-2683){ref-type="fig"}.

Rapid early bone formation was observed at 4 weeks postimplantation. The results showed that a thin layer of trabecular bone formed under both PGS membranes and collagen membranes and was evenly distributed in most of the defects ([Figure 2A](#f2-ijn-14-2683){ref-type="fig"}). The BV/TV of the samples at 4 weeks in the 25 µm PGS group was higher than that in the 53 µm PGS and collagen groups ([Figure 2B](#f2-ijn-14-2683){ref-type="fig"}) and was higher in the 53 µm PGS group than in the collagen group. Accordingly, trabecular thickness (Tb.Th) and trabecular separation (Tb.Sp) in the 25 µm PGS group indicated superior osteogenesis to that of the other two groups, and trabecular number (Tb.N) was the same as that of the 53 µm group. This result confirmed the osteoconductive property of the PGS membrane. At 12 weeks, the 25 µm PGS membrane guided the formation of lamellar bone. Micro-CT images clearly showed that the new bone grew from the lateral margins, and thickened trabecula formed within the defects in both PGS membrane groups (25 and 53 µm) and the collagen membrane group ([Figure 3A](#f3-ijn-14-2683){ref-type="fig"}). In the 25 µm PGS group, the new bone beneath the membrane almost completely covered the defect site. However, in the collagen membrane group or 53 µm PGS group, although the new bone beneath the membrane covered most of the defect areas, a portion was left uncovered. Quantitative analyses of trabecular thickness and trabecular separation showed that the distribution of regenerated bone under the PGS membranes was fairly uniform; the maximum trabecular thickness was 0.40±0.06 mm, and the minimum trabecular separation was 1.25±0.10 mm ([Figure 3B](#f3-ijn-14-2683){ref-type="fig"}). Furthermore, the trabecular thickness in the 25 µm membrane group was significantly greater than that in the other two groups, whereas the 53 µm PGS and collagen membrane groups exhibited similar values for Tb.Th and Tb.Sp.

Histological observation further verified these findings ([Figure 4](#f4-ijn-14-2683){ref-type="fig"}).

In the untreated control group, the healing areas of tibial defects were mainly bridged by fibrous connective tissue, and bone formation was limited to the edge of the host bone. Specifically, a three-layer bone structure was clearly visible in the PGS and collagen membrane groups. At 4 weeks, almost all of the bone defect areas in all treatment groups (25 µm PGS membrane, 53 µm PGS membrane, and collagen membrane) were almost entirely closed by immature trabecular bone. There were a greater number of small vascular channels in the new bone structure, which appeared to facilitate the differentiation of new bone from the host bone. However, the vertical height of newly formed trabecula varied significantly. Collagen membranes were completely absorbed, no inflammation was detected, and newly formed bone bridges without obvious collapse in the defect site were observed. Most of the 53 µm PGS membranes were degraded at 4 weeks, and fibrous tissues occupied the upper half of the newly formed trabecula, thus compromising the thickness of the new bone. Most of the 25 µm PGS membranes remained on the defect site, and a certain number of trabeculae formed beneath the PGS membrane, with no significant difference in the vertical height of bone as compared with that observed for collagen membranes. At 12 weeks, however, only the 25 µm PGS membrane guided the complete coverage of the defect by mature, lamellar bone, with adequate thickness as well as a smooth surface. The remainder of PGS membrane was completely degraded, and no inflammation was observed at cellular level. In the 53 µm PGS membrane and collagen membrane groups, subtotal repair with immature bone was observed, and the remaining unhealed area was covered by fibrous connective tissue.

Histological staining (eg, Alizarin red/von Kossa) is an important staining method to confirm the structural properties of bone matrix.[@b26-ijn-14-2683] However, because the tissue sections in the experiment were decalcified sections, Alizarin red/von Kossa staining method was not used. In fact, in several studies, decalcified sections have been widely used in the identification of bone matrix structures.[@b20-ijn-14-2683],[@b27-ijn-14-2683],[@b28-ijn-14-2683]

Discussion
==========

Our goal was to develop an elastomeric GBR membrane that reduces hydroxyapatite or titanium mesh administration in clinical practice. We developed a biocompatible membrane using a tough and elastomeric polymer, PGS. The resultant biomaterials exhibited tunable pore sizes and high porosity, resulting in satisfactory resilience to external loading and favorable supportive performance when covering defects.

PGS not only has good osteogenic properties and biocompatibility[@b29-ijn-14-2683],[@b30-ijn-14-2683] but also has good mechanical and selective osmotic properties as well as an easily defined material structure, which makes it a very promising material for GBR therapy. Therefore, in this study, we fabricated micro-porous PGS membranes with specific structures using a mold to investigate their effects on bone regeneration in GBR therapy.

During the GBR procedure, the PGS membranes effectively adhered to the bone tissue surrounding the defect, without additional grafting material and fixation pins. Based on a gross specimen inspection, the PGS membranes remained in place and maintained support and structural integrity before their complete degradation. Moreover, PGS membranes have better elasticity and mechanical compatibility with bone and surrounding tissues than those of hydroxyapatite filling-supported membranes and titanium-based membranes. This reduces the risk of exposure caused by mucosal perforation. It is worth mentioning that in our study, there was no significant swelling and inflammation in the healing area of bone defect in the PGS/collagen group as well as in the blank control group. This good prognosis reflects the good biocompatibility of PGS membrane to a certain extent.

As a kind of biodegradable polymer, the degradation period of PGS membranes ranges from 1 month to 2 months according to the pore size and interconnectivity. We found that the 25 µm PGS membrane was retained for a longer time than the 53 µm membrane. The difference in the microarchitecture of PGS membranes could explain the variation in degradation rates. Infiltrated macrophages are involved in PGS scaffold-mediated tissue remodeling.[@b31-ijn-14-2683] A histological analysis confirmed that cell infiltration at as early as 4 weeks was significantly greater for the 25 µm membrane than for the 53 µm membrane, and this infiltration included macrophages, leukocytes, fibroblasts, and myofibroblasts. These results had been confirmed in our relevant studies.[@b32-ijn-14-2683] We therefore concluded that infiltrating cells promoted resorption of the PGS membrane. Recently, a PGS membrane fabricated by electrospinning techniques showed significantly smaller pores than membranes fabricated by salt-leaching techniques, which have been reported to enhance mechanical strength. For the clinical application of GBR, early events, such as protein adsorption, cell adhesion, and apatite formation, in the process of new bone formation are vulnerable to the effects of microstructures, which are essential for subsequent osteoblast functions, such as cell proliferation and calcium mineral differentiation and deposition.[@b33-ijn-14-2683] A study of biological activity and osteogenesis in vivo confirmed that the osteoconductivity of the PGS membrane is superior to that of biomembranes, which are prone to collapse. These results also suggest that PGS materials with a multilayered nanoarchitecture, if properly designed, can improve the osteogenic bioactivity and thus improve bone regeneration. Therefore, the rational design of pore size, including microarchitectures fabricated by the electrospinning technique, should be investigated in further studies.

An essential factor for GBR techniques is the maintenance of space at the defect site with the coverage of GBR membranes. Clot maintenance is critical for subsequent bone remodeling and osteogenesis. Interestingly, PGS membranes with different pore sizes and collagen membranes show significant differences in degradation rates. Moreover, the number and quality of trabecular bone have an important effect on the formation of new bone in the bone defect area. At 4 weeks, however, there was no significant difference in the number of new bone trabeculae between the PGS membrane group and the collagen membrane group. These results revealed the early therapeutic effect of biomaterial coverage on bone defects. At this time point, the collagen membrane was almost completely degraded; 70% of the 53 µm PGS membrane was degraded and 30% of the 25 µm PGS membrane was degraded on average ([Figure 1I](#f1-ijn-14-2683){ref-type="fig"}). Since the GBR membranes in individual groups degraded significantly after 4 weeks, there was obvious variation among groups at 3 months. Early collapse may decrease the vertical height of new bone. Additionally, early degradation may compromise bone quality owing to the mixture of fibroblasts. We thus concluded that the 25 µm PGS membrane is advantageous during the period from 4 to 12 weeks compared with earlier degrading counterparts.

The choice of animal models of bone defects is a very important consideration for studies of osteogenesis.[@b34-ijn-14-2683] The regeneration of new bone in the defect area differs substantially between cranial flat bones and long bones owing to the different origin of embryonic tissue.[@b35-ijn-14-2683] Cranial flat bone regenerates new bone by intramembranous ossification; however, both endochondral ossification and intramembranous ossification occur during long bone regeneration.[@b36-ijn-14-2683],[@b37-ijn-14-2683] In the study by Zaky et al,[@b30-ijn-14-2683],[@b33-ijn-14-2683] they investigated polyglycerol sebacate (PGS) in vivo for the regeneration of a rabbit ulna critical size defect. Their study confirmed PGS to be osteoconductive contributing to bone regeneration by recruiting host progenitor/stem cell populations and as a load-transducing substrate. Also, they concluded that the material properties of PGS being closer to osteoid tissue rather than to mineralized bone. Based on the results of other studies, we boldly selected the GBR surgical area on the tibia of rabbits in our study and considered to further verify the bone regeneration ability of PGS materials in relatively large load areas. Due to dynamic mechanical loading, the formation of new bone in the bone defect area is faced with certain challenges. In the present study, at 4 weeks, there was a difference in early osteogenesis in defects shielded with different GBR membranes in vivo. Blood clot and callus quantities were significantly greater in the PGS microporous membrane group, while the collapse of the collagen membrane or macroporous PGS membrane obviously reduced osteogenesis. The difference further confirmed that the tibial defect model was appropriate to reveal the discrepancies in GBR physical properties.

These findings suggest a potential pathway for continued progress in PGS membrane-guided osteogenesis. Moreover, many studies have shown that synergistic signal transduction between the physical properties of biomaterials and growth factor signaling may accelerate bone healing.[@b38-ijn-14-2683] Some scholars have proposed a strategy for the combination of bio-materials and low-dose bone morphogenetic protein (BMP) (\<150 ng).[@b39-ijn-14-2683] Of course, the safe use of growth factors is very important for clinical applications. Ongoing experiments include the incorporation of growth factors into the scaffold,[@b40-ijn-14-2683] such as platelet-rich fibrin, a popular source of endogenous growth factors, for improved osteogenesis.

Conclusion
==========

We believe that the degradation time and mechanical strength of PGS membrane can be well controlled by controlling the pore size of the PGS membrane, which provides the necessary time, space, and nutrients to assure the formation of new bone. Compared with the early degraded biomembrane, the 25 µm PGS membrane had obvious advantages in the protection of blood clots and the formation of new bone in 4--12 weeks.
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![Structure and physical properties of the PGS membranes based on the GBR model of bone defects in rabbit tibia.\
**Notes:** (**A**) SEM image of the cross-section of a freeze-dried 25 µm PGS membrane, 53 µm PGS membrane, and collagen membrane (Bio-Gide); scale bar, 50 µm or 200 µm. A suture pullout test (**B**) and tensile test (**C**) were performed (\**p*\<0.05; mean ± SD; A: n=5, B: n=6, C: n=6). Compared with the control group, PGS membranes (25 µm and 53 µm) had lower mechanical strength and breaking strain. (**D**) Elastic modulus results are presented as mean ± SD (\**p*\<0.05, mean ± SD, n=6). (**E**) Bulk densities are presented as mean ± SD (\**p*\<0.05, \*\**p*\<0.01, mean ± SD, n=6). (**F**, **G**) A permeability test was performed using PGS and Bio-Gide membranes. (**H**) Images of the surgical operation using the PGS membranes for the closure of tibial defects in rabbits. (**I**) Images of the bone sample for 25 µm PGS membranes at 4 weeks. There was a small piece of completely undegraded PGS membrane at the bone defect site.\
**Abbreviations:** GBR, guided bone regeneration; PGS, polyglycerol sebacate; SEM, scanning electron microscopy.](ijn-14-2683Fig1){#f1-ijn-14-2683}

![Micro-CT scanning images and analysis results at the end of 4 weeks.\
**Notes:** (**A**) Bone defect models with or without membranes were scanned by micro-CT at 4 weeks postimplantation. In the 25 µm PGS, 53 µm PGS, and Bio-Gide membrane groups, regenerated cancellous bone covered the whole defect site after 4 weeks of implantation. (**B**) Volume ratios of regenerated bone were evaluated quantitatively in each group. BV/TV, Tb.Th, Tb.N, and Tb.Sp are presented as mean ± SD (\**p*\<0.05, \*\**p*\<0.01, n=16). At 4 weeks postimplantation, in the 25 µm PGS and 53 µm PGS groups, the volume ratios of newly formed bone were significantly higher than those in the Bio-Gide group and blank control group. "NS" indicates no significant difference among the PGS and Bio-Gide groups (*p*\>0.05, mean ± SD, n=16).\
**Abbreviations:** CT, computed tomography; PGS, polyglycerol sebacate; Tb.N, trabecular number; Tb.Sp, trabecular separation; Tb.Th, trabecular thickness; w, week; BV/TV, bone volume to tissue volume.](ijn-14-2683Fig2){#f2-ijn-14-2683}

![Micro-CT scanning images and analysis results at the end of 12 weeks.\
**Notes:** (**A**) Bone defect models with or without membranes were scanned by micro-CT at 12 weeks postimplantation. In the 25 µm PGS, 53 µm PGS, and Bio-Gide membrane groups, regenerated mature lamellar bone covered the whole defect site after 12 weeks of implantation. (**B**) Volume ratios of regenerated bone were evaluated quantitatively in each group. BV/TV, Tb.Th, Tb.N, and Tb.Sp are presented as mean ± SD (\**p*\<0.05, \*\**p*\<0.01, n=16). At 12 weeks postimplantation, in the 25 µm PGS group, the volume ratio of newly formed bone was significantly higher than those in the 53 µm PGS group, Bio-Gide, and blank control groups. "NS" indicates no significant difference among the 53 µm PGS group and the Bio-Gide group (*p*\>0.05, mean ± SD, n=16).\
**Abbreviations:** CT, computed tomography; PGS, polyglycerol sebacate; Tb.N, trabecular number; Tb.Sp, trabecular separation; Tb.Th, trabecular thickness; w, week.](ijn-14-2683Fig3){#f3-ijn-14-2683}

![Histological analysis results at the end of 4 and 12 weeks. H&E-stained images of regenerated bone at 4 weeks (**A**--**D**) and 12 weeks (**E**--**H**) after membrane implantation. The entire images (left) and magnified images (right) were separated on both sides. The boxed areas in the images on the left show the lateral margin and central region of the rabbit tibia defect beneath the membranes. The images on the right show H&E staining and Masson's trichrome staining. In the tested membrane group, the transition of newly formed bone from cancellous bone to mature lamellar bone structure was observed.\
**Abbreviation:** w, week.](ijn-14-2683Fig4){#f4-ijn-14-2683}
